Table 2.
Demographics and Clinicopathological Characteristics of the Study Patients.
| Variables | Ajwa Intake |
P Value | |
|---|---|---|---|
| Yes, n (%) | No, n (%) | ||
| Gender | |||
| Male | 14 (54) | 17 (57) | .786 |
| Female | 12 (46) | 13 (43) | |
| Ethnicity | |||
| Sothern Asian | 2 (40) | 3 (60) | .502 |
| Southeastern Asian | 8 (44) | 10 (56) | |
| Western Asian | 11 (48) | 12 (52) | |
| African | 2 (20) | 8 (80) | |
| Type of cancer | |||
| Hematological | 17 (45) | 21 (55) | .418 |
| Nonhematological | 6 (33) | 12 (67) | |
| Relapse of cancer | |||
| Yes | 5 (56) | 4 (44) | .335 |
| No | 18 (38) | 29 (62) | |
| Stage of cancer | |||
| Early stage | 8 (53) | 7 (47) | .259 |
| Advanced stage | 15 (37) | 26 (63) | |
| Radiotherapy statusa | |||
| Yes | 5 (50) | 5 (50) | .527 |
| No | 18 (39) | 28 (61) | |
a
All patients were on chemotherapy, whereas radiotherapy was applied based on the chemotherapy protocol. Mean age ± SD = 9.1 ± 4.1 years.